BR0011678A - Composições farmacêuticas compreendendo complexos de metal - Google Patents
Composições farmacêuticas compreendendo complexos de metalInfo
- Publication number
- BR0011678A BR0011678A BR0011678-5A BR0011678A BR0011678A BR 0011678 A BR0011678 A BR 0011678A BR 0011678 A BR0011678 A BR 0011678A BR 0011678 A BR0011678 A BR 0011678A
- Authority
- BR
- Brazil
- Prior art keywords
- group
- mixture
- pharmaceutical compositions
- metal complexes
- ions
- Prior art date
Links
- 229910052751 metal Inorganic materials 0.000 title abstract 2
- 239000002184 metal Substances 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 5
- 239000003446 ligand Substances 0.000 abstract 4
- -1 pseudohalide ion Chemical class 0.000 abstract 3
- 150000001768 cations Chemical group 0.000 abstract 2
- 229910021480 group 4 element Inorganic materials 0.000 abstract 2
- 229910021478 group 5 element Inorganic materials 0.000 abstract 2
- 229910021476 group 6 element Inorganic materials 0.000 abstract 2
- 229910021645 metal ion Inorganic materials 0.000 abstract 2
- 230000000737 periodic effect Effects 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000004820 halides Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F19/00—Metal compounds according to more than one of main groups C07F1/00 - C07F17/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0046—Ruthenium compounds
- C07F15/0053—Ruthenium compounds without a metal-carbon linkage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/295—Iron group metal compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12516699P | 1999-03-19 | 1999-03-19 | |
| PCT/CA2000/000294 WO2000056743A1 (en) | 1999-03-19 | 2000-03-17 | Pharmaceutical compositions comprising metal complexes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0011678A true BR0011678A (pt) | 2002-02-26 |
Family
ID=22418482
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0011678-5A BR0011678A (pt) | 1999-03-19 | 2000-03-17 | Composições farmacêuticas compreendendo complexos de metal |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20020049190A1 (https=) |
| EP (1) | EP1163247A1 (https=) |
| JP (1) | JP2004500321A (https=) |
| KR (1) | KR20010112343A (https=) |
| CN (1) | CN1391577A (https=) |
| AU (1) | AU3268500A (https=) |
| BR (1) | BR0011678A (https=) |
| CA (1) | CA2367282A1 (https=) |
| CZ (1) | CZ20013307A3 (https=) |
| HU (1) | HUP0400457A2 (https=) |
| IL (1) | IL145290A0 (https=) |
| MX (1) | MXPA01009410A (https=) |
| NO (1) | NO20014526L (https=) |
| PL (1) | PL356683A1 (https=) |
| WO (1) | WO2000056743A1 (https=) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1916009B (zh) | 1999-04-13 | 2010-12-15 | 阿诺麦德股份有限公司 | 制备胺铂配合物的方法 |
| JP4227701B2 (ja) * | 1999-05-25 | 2009-02-18 | 中部キレスト株式会社 | ジエチレントリアミン五酢酸ルテニウム二アンモニウム塩またはその水和物およびその製法 |
| US6489638B2 (en) * | 2000-06-23 | 2002-12-03 | Semiconductor Energy Laboratory Co., Ltd. | Light emitting device |
| US6894049B1 (en) | 2000-10-04 | 2005-05-17 | Anormed, Inc. | Platinum complexes as antitumor agents |
| US20020072512A1 (en) * | 2000-12-08 | 2002-06-13 | Metaphore Pharmaceuticals, Inc | Method of preventing and treating HIV-mediated central nervous system damage |
| GB0111872D0 (en) * | 2001-05-15 | 2001-07-04 | Northwick Park Inst For Medica | Therapeutic agents and methods |
| NZ534912A (en) * | 2002-02-04 | 2007-08-31 | Alfama Investigacao E Desenvol | supramolecule aggregate comprising CO containing organometallic or transition metal complex and anti-inflammatory agent or biphosphonate phosphonate derivative |
| GB2395432B (en) * | 2002-11-20 | 2005-09-14 | Northwick Park Inst For Medica | Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs |
| GB2395431A (en) * | 2002-11-20 | 2004-05-26 | Northwick Park Inst For Medica | Combination of a metal carbonyl compound and a guanylate cyclase stimulant or stabilizer for the therapeutic delivery of carbon monoxide |
| US7737179B2 (en) * | 2003-08-04 | 2010-06-15 | J&J Consumer Companies, Inc. | Methods for treatment of dermatological conditions |
| AU2005210285B2 (en) | 2004-02-05 | 2008-01-24 | Kyorin Pharmaceutical Co., Ltd. | Bicycloester derivative |
| FR2873037B1 (fr) | 2004-07-13 | 2008-04-11 | Univ Pasteur | Methodes et compositions pour le traitement de cancers |
| MX2008008104A (es) * | 2005-12-21 | 2008-09-03 | Oxford Biosensors Ltd | Mediadores redox. |
| GB0601394D0 (en) | 2006-01-24 | 2006-03-01 | Hemocorm Ltd | Therapeutic delivery of carbon monoxide |
| EP1995237A4 (en) | 2006-03-08 | 2011-07-06 | Kyorin Seiyaku Kk | PROCESS FOR PREPARING AN AMINOACETYLPYRROLIDINCARBONITRILE DERIVATIVE AND PRODUCTION PRODUCT THEREOF |
| ES2444695T3 (es) | 2006-06-23 | 2014-02-26 | Alethia Biotherapeutics Inc. | Polinucleótidos y polipéptidos implicados en el cáncer |
| WO2008038305A2 (en) * | 2006-09-26 | 2008-04-03 | Jegannathan Srinivas | Therapeutical formulation comprising a thiazolidinedione and a nitric oxide scavenger. |
| WO2008114857A1 (ja) | 2007-03-22 | 2008-09-25 | Kyorin Pharmaceutical Co., Ltd. | アミノアセチルピロリジンカルボニトリル誘導体の製造方法 |
| CA2740900C (en) | 2008-11-03 | 2019-09-24 | Alethia Biotherapeutics Inc. | Antibodies that specifically block the biological activity of a tumor antigen |
| DE102010014412A1 (de) | 2010-04-08 | 2012-04-19 | Friedrich-Schiller-Universität Jena | Verwendung von zweikernigen Eisenkomplexen mit schwefelhaltigen Liganden als pharmakologische Wirkstoffe |
| DE102010014411A1 (de) | 2010-04-08 | 2011-10-13 | Friedrich-Schiller-Universität Jena | Kohlenmonoxid und Eisen freisetzende Moleküle, deren Verwendung und Verfahren zu deren Herstellung |
| SI3173427T1 (sl) | 2011-03-31 | 2019-08-30 | ADC Therapeutics SA, | Protitelesa proti antigenu 1, povezanemu z ledvicami, in antigen vezavni fragmenti le-tega |
| EP2699242B1 (en) | 2011-04-19 | 2017-11-01 | Alfama, Inc. | Carbon monoxide releasing molecules and uses thereof |
| JP6134710B2 (ja) | 2011-07-21 | 2017-05-24 | アルファーマ インコーポレイテッドＡｌｆａｍａ，Ｉｎｃ． | 一酸化ルテニウム放出分子およびその使用 |
| KR102102239B1 (ko) | 2012-01-09 | 2020-04-21 | 에이디씨 테라퓨틱스 에스에이 | 유방암을 치료하기 위한 방법 |
| DE102012004132A1 (de) | 2012-02-29 | 2013-08-29 | Friedrich-Schiller-Universität Jena | Kohlenstoffmonoxid freisetzende Materialien und deren Verwendung |
| DE102014008537A1 (de) | 2014-06-04 | 2015-12-17 | Friedrich-Schiller-Universität Jena | Wasserlösliche manganbasierte Kohlenstoffmonoxid freisetzende Moleküle, deren Verwendung und Verfahren zu deren Herstellung |
| EP3212610B1 (en) * | 2014-10-30 | 2020-10-28 | Katholieke Universiteit Leuven | Methods for low temperature fluorine-18 radiolabeling of biomolecules |
| CN113429456B (zh) * | 2021-06-11 | 2022-05-31 | 首都医科大学 | 多肽衍生物钌类络合物及其制备方法和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5112974A (en) * | 1985-01-18 | 1992-05-12 | The Trustees Of Columbia University In The City Of New York | Mixed ligand complexes and uses thereof as binding agents to DNA |
| US4721669A (en) * | 1985-01-18 | 1988-01-26 | The Trustees Of Columbia University In The City Of New York | Chemical probes for left-handed DNA and chiral metal complexes as Z-specific anti-tumor agents |
| GB9317686D0 (en) * | 1993-08-25 | 1993-10-13 | Johnson Matthey Plc | Pharmaceutical compositions |
| SE9703396D0 (sv) * | 1997-09-19 | 1997-09-19 | Lincoln | Binuclear complex |
-
2000
- 2000-03-17 AU AU32685/00A patent/AU3268500A/en not_active Abandoned
- 2000-03-17 IL IL14529000A patent/IL145290A0/xx unknown
- 2000-03-17 EP EP00910468A patent/EP1163247A1/en not_active Withdrawn
- 2000-03-17 WO PCT/CA2000/000294 patent/WO2000056743A1/en not_active Ceased
- 2000-03-17 CA CA002367282A patent/CA2367282A1/en not_active Abandoned
- 2000-03-17 CZ CZ20013307A patent/CZ20013307A3/cs unknown
- 2000-03-17 KR KR1020017011819A patent/KR20010112343A/ko not_active Withdrawn
- 2000-03-17 CN CN00806748A patent/CN1391577A/zh active Pending
- 2000-03-17 BR BR0011678-5A patent/BR0011678A/pt not_active Application Discontinuation
- 2000-03-17 HU HU0400457A patent/HUP0400457A2/hu unknown
- 2000-03-17 MX MXPA01009410A patent/MXPA01009410A/es unknown
- 2000-03-17 JP JP2000606604A patent/JP2004500321A/ja not_active Withdrawn
- 2000-03-17 US US09/527,450 patent/US20020049190A1/en not_active Abandoned
- 2000-03-17 PL PL00356683A patent/PL356683A1/xx not_active Application Discontinuation
-
2001
- 2001-09-18 NO NO20014526A patent/NO20014526L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA01009410A (es) | 2003-06-06 |
| CZ20013307A3 (cs) | 2002-05-15 |
| WO2000056743A1 (en) | 2000-09-28 |
| NO20014526L (no) | 2001-10-16 |
| NO20014526D0 (no) | 2001-09-18 |
| US20020049190A1 (en) | 2002-04-25 |
| PL356683A1 (en) | 2004-06-28 |
| IL145290A0 (en) | 2002-06-30 |
| CA2367282A1 (en) | 2000-09-28 |
| EP1163247A1 (en) | 2001-12-19 |
| CN1391577A (zh) | 2003-01-15 |
| HUP0400457A2 (hu) | 2004-05-28 |
| JP2004500321A (ja) | 2004-01-08 |
| KR20010112343A (ko) | 2001-12-20 |
| AU3268500A (en) | 2000-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0011678A (pt) | Composições farmacêuticas compreendendo complexos de metal | |
| PL348451A1 (en) | Glycopeptide derivatives and pharmaceutical compositions containing the same | |
| KR900002784A (ko) | 항종양치료에 사용하기 위한 약제학적 결합제제 | |
| TW239126B (https=) | ||
| HUP0102422A3 (en) | Isothiazole derivatives useful as anticancer agents, pharmaceutical compositions containing such compounds and processes for their preparation | |
| IL103301A0 (en) | Pyrimidine nucleoside derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| TW272195B (https=) | ||
| IL73632A (en) | N-acylated substituted trans-1,2-diaminocyclohexane compounds,their preparation and pharmaceutical compositions containing them | |
| DE60204452D1 (de) | Pyrazolo[1,5]pyridinderivate | |
| BRPI0215312B8 (pt) | composto, uso de um composto, composição farmacêutica, e processo para a preparação de um composto | |
| CA2111527A1 (en) | Phosphonooxymethyl Ethers of Taxane Derivatives | |
| ATE255129T1 (de) | Hemmer von apoptose | |
| BR0214038A (pt) | Composições catalisadoras de imino-amida para a polimerização de olefinas | |
| TW349094B (en) | Compositions and methods for controlling harmful fungi | |
| BG102673A (bg) | Смеси, добивани от зърна на еugеniа jамвоlаnа lамаrск, получаване и използване на посочените смеси и някои техни компоненти като лекарства | |
| CA2186731A1 (en) | Trinuclear cationic platinum complexes having antitumour activity and pharmaceutical compositions containing them | |
| ATE344230T1 (de) | Triphenylbutenderivate zur behandlung von neurologischen störungen | |
| KR890014107A (ko) | 백금 화학 요법약제 | |
| DE60211500D1 (de) | Metallkomplexe und deren therapeutische verwendungen | |
| MA24721A1 (fr) | Compositions nouvelles renfermant des derives de benzopyranne et pyrydopyranne et procede pour leur preparation | |
| IL147890A0 (en) | Pharmaceutical compositions containing pentafluorobenzenesulfonamide derivatives | |
| BR9608473A (pt) | Complexo organometálico do ferro, composição para o tratamento do paludismo, e, utilização de um composto | |
| ATE236179T1 (de) | Nitrate von bis-platinum komplexen mit polyamin | |
| CA2165887A1 (en) | Complexes of the Lanthanides with Heterocyclic Carbenes | |
| KR910006217A (ko) | 디히드로카페인산 유도체 및 이를 함유하는 약학제제 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |